98%
921
2 minutes
20
Aortic dissection (AD) is a serious life-threatening vascular disease. However, research on type B blind cystic AD is still insufficient. This type of AD involves only one proximal intimal tear, and the distal end of the aortic false lumen (FL) is a blind sac. The purpose of this study was to explore the haemodynamic indicators of retearing and high-risk areas for FL rupture in type B blind cystic AD patients. This study included 4 cases of type B blind cystic AD rupture death, which revealed the pathological characteristics of the aorta. In addition, imaging data from one deceased and four patients with type B AD (TBAD) with multiple intimal tears were collected, and two groups of models (n = 10) were constructed. The pressure, velocity, time-averaged wall shear stress (TAWSS), and relative residence time (RRT) were compared to interpret our autopsy results. In type B blind cystic AD patients, the FL is characterized by high pressure, a low TAWSS, and high RRT. There was a relatively high TAWSS in the FL adjacent to the proximal intimal tear; at the same time, both the blood flow velocity and the pressure difference in the true lumen (TL) significantly changed. In addition, the greater the curvature of the aorta is, the more drastic the change in the luminal pressure difference. In type B blind cystic AD, high pressure may be the main reason for FL rupture, and the FL adjacent to the proximal intimal tear may be a high-risk rupture area. In addition, alterations in blood flow velocity and differential pressure may cause distal intimal retears. Tortuosity is an important indicator for studying pressure changes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s13246-025-01552-y | DOI Listing |
Pain Manag
September 2025
Minimally Invasive Gynecologic Surgery, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Background: Gynecologic enhanced recovery after surgery (ERAS) pathways have been developed to reduce postoperative narcotic use through multimodal pain management. While incisional injection of local anesthetic is standard practice, regional nerve blockades using liposomal agents are emerging as a promising adjunct technique for post-laparoscopy pain. Current data are conflicting regarding the benefits of regional nerve blocks on postoperative pain after laparoscopic hysterectomy.
View Article and Find Full Text PDFAim: The purpose of this study was to assess whether the use of spray-type anti-adhesion material during diverting ileostomy construction could reduce the surgeon's multidimensional workload, the degree of adhesion, and the operation time in ileostomy closure.
Methods: Patients diagnosed with rectal cancer, who were scheduled for laparoscopic or robotic rectal surgery followed by diverting ileostomy, were single-blindly (patient-blind), randomly assigned to either the AdSpray™ arm or the control arm. The primary endpoint was the multidimensional workload of the ileostomy closure operator (SURG-TLX value).
Cardiovasc Diabetol
September 2025
Computational Biomedicine, Center for Thrombosis and Hemostasis (CTH), Mainz, Germany.
Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as Empagliflozin, are antidiabetic drugs that reduce glucose levels and have emerged as a promising therapy for patients with heart failure (HF), although the exact molecular mechanisms underlying their cardioprotective effects remain to be fully elucidated. The EmDia study, a randomized, double-blind trial conducted at the University Medical Center of Mainz, has confirmed the beneficial effects of Empagliflozin in HF patients after both one and twelve weeks of treatment. In this work, we aimed to assess whether changes in lipid profiles driven by Empagliflozin use in HF patients in the EmDia trial could assist in gaining a better understanding of its cardioprotective mechanisms.
View Article and Find Full Text PDFObjectives: Cocaine use disorder (CUD) affects 1.4 million people in the United States, yet no FDA-approved treatments exist. In 2023, the Food and Drug Administration (FDA) released a draft guideline on treatments for stimulant use disorders, providing direction for trial design, outcomes, and population selection.
View Article and Find Full Text PDFLancet Reg Health West Pac
September 2025
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, China.
Background: Cecolin9, a second-generation 9-valent HPV vaccine derived from the WHO-prequalified Cecolin, has received marketing authorisation in China in May 2025. The non-inferiority of type-specific immune responses between Cecolin9 and Gardasil9 has been previously established at month 7 in Chinese women aged 18-26 years (NCT04782895). This study aimed to compare the plateau antibody levels between the two vaccines three years post the first dose.
View Article and Find Full Text PDF